These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34756880)

  • 1. Human Papillomavirus‒Positive and ‒Negative Vulvar Squamous Cell Carcinoma Are Biologically but Not Clinically Distinct.
    Kolitz E; Lucas E; Hosler GA; Kim J; Hammer S; Lewis C; Xu L; Day AT; Mauskar M; Lea JS; Wang RC
    J Invest Dermatol; 2022 May; 142(5):1280-1290.e7. PubMed ID: 34756880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV-independent Vulvar Squamous Cell Carcinoma is Associated With Significantly Worse Prognosis Compared With HPV-associated Tumors.
    Allo G; Yap ML; Cuartero J; Milosevic M; Ferguson S; Mackay H; Kamel-Reid S; Weinreb I; Ghazarian D; Pintilie M; Clarke BA
    Int J Gynecol Pathol; 2020 Jul; 39(4):391-399. PubMed ID: 31274700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanding the Morphologic, Immunohistochemical, and HPV Genotypic Features of High-grade Squamous Intraepithelial Lesions of the Vulva With Morphology Mimicking Differentiated Vulvar Intraepithelial Neoplasia and/or Lichen Sclerosus.
    Griesinger LM; Walline H; Wang GY; Lorenzatti Hiles G; Welch KC; Haefner HK; Lieberman RW; Skala SL
    Int J Gynecol Pathol; 2021 May; 40(3):205-213. PubMed ID: 32925443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus infection and p16(INK4a) protein expression in vulvar intraepithelial neoplasia and invasive squamous cell carcinoma.
    Rufforny I; Wilkinson EJ; Liu C; Zhu H; Buteral M; Massoll NA
    J Low Genit Tract Dis; 2005 Apr; 9(2):108-13. PubMed ID: 15870532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular subclassification of vulvar squamous cell carcinoma: reproducibility and prognostic significance of a novel surgical technique.
    Thompson EF; Hoang L; Höhn AK; Palicelli A; Talia KL; Tchrakian N; Senz J; Rusike R; Jordan S; Jamieson A; Huvila J; McAlpine JN; Gilks CB; Höckel M; Singh N; Horn LC
    Int J Gynecol Cancer; 2022 Aug; 32(8):977-985. PubMed ID: 35764349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Basal cell carcinomas of the vulva: high-risk human papillomavirus DNA detection, p16 and BerEP4 expression.
    Elwood H; Kim J; Yemelyanova A; Ronnett BM; Taube JM
    Am J Surg Pathol; 2014 Apr; 38(4):542-7. PubMed ID: 24625418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?
    Alonso I; Fusté V; del Pino M; Castillo P; Torné A; Fusté P; Rios J; Pahisa J; Balasch J; Ordi J
    Gynecol Oncol; 2011 Sep; 122(3):509-14. PubMed ID: 21652058
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lozar T; Keske A; Dube Mandishora RS; Yu Q; Bailey A; Xu J; Tommasino M; McGregor SM; Lambert PF; Gheit T; Fitzpatrick MB
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of HPV-PCR, p16 and p53 immunohistochemical status on local recurrence rate and survival in patients with vulvar squamous cell carcinoma.
    Pouwer AW; Te Grootenhuis NC; Hinten F; de Bock GH; van der Zee AGJ; Melchers WJG; Oonk MHM; de Hullu JA; Hollema H; Bulten J
    Virchows Arch; 2024 Jun; 484(6):985-994. PubMed ID: 37938322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
    Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
    Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer.
    Schlecht NF; Brandwein-Gensler M; Nuovo GJ; Li M; Dunne A; Kawachi N; Smith RV; Burk RD; Prystowsky MB
    Mod Pathol; 2011 Oct; 24(10):1295-305. PubMed ID: 21572401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD274 (PD-L1), CDKN2A (p16), TP53, and EGFR immunohistochemical profile in primary, recurrent and metastatic vulvar cancer.
    Lérias S; Esteves S; Silva F; Cunha M; Cochicho D; Martins L; Félix A
    Mod Pathol; 2020 May; 33(5):893-904. PubMed ID: 31844270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16INK4A expression as biomarker for HPV 16-related vulvar neoplasias.
    Riethdorf S; Neffen EF; Cviko A; Löning T; Crum CP; Riethdorf L
    Hum Pathol; 2004 Dec; 35(12):1477-83. PubMed ID: 15619206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of human papilloma virus status and response to radiotherapy in vulvar squamous cell carcinoma.
    Proctor L; Hoang L; Moore J; Thompson E; Leung S; Natesan D; Chino J; Gilks B; McAlpine JN
    Int J Gynecol Cancer; 2020 Jan; 30(1):100-106. PubMed ID: 31771962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group.
    Woelber L; Prieske K; Eulenburg C; Oliveira-Ferrer L; de Gregorio N; Klapdor R; Kalder M; Braicu I; Fuerst S; Klar M; Strauss HG; Beckmann M; Meier W; Ignatov A; Mustea A; Jueckstock J; Schmidt G; Bauerschlag D; Hellriegel M; Canzler U; Petry KU; Kommoss S; Hantschmann P; Heubner M; Mahner S; Burandt E
    Am J Obstet Gynecol; 2021 Jun; 224(6):595.e1-595.e11. PubMed ID: 33453182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome.
    Kuo KT; Hsiao CH; Lin CH; Kuo LT; Huang SH; Lin MC
    Mod Pathol; 2008 Apr; 21(4):376-86. PubMed ID: 18223558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of p16(INK4A), MIB1 and p53 proteins can distinguish between the 2 pathways leading to vulvar squamous cell carcinoma.
    Hoevenaars BM; van der Avoort IA; de Wilde PC; Massuger LF; Melchers WJ; de Hullu JA; Bulten J
    Int J Cancer; 2008 Dec; 123(12):2767-73. PubMed ID: 18798277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Histological characteristics of HPV-associated and -independent squamous cell carcinomas of the vulva: A study of 1,594 cases".
    Rakislova N; Clavero O; Alemany L; Saco A; Quirós B; Lloveras B; Alejo M; Pawlita M; Quint W; Del Pino M; de Sanjose S; Ordi J;
    Int J Cancer; 2017 Dec; 141(12):2517-2527. PubMed ID: 28815579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.